Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
150 participants
INTERVENTIONAL
2014-09-30
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Incidence of Trauma Induced Coagulopathy in Patients With Prehospital Administration of Fibrinogen
NCT03572309
Evaluation of the Minimum Concentration of Tranexamic Acid Required to Inhibit Fibrinolysis in a Population of Pregnant Women at Term.
NCT02579941
Freeze-dried Plasma in the Initial Management of Coagulopathy in Trauma Patients
NCT02750150
Transfusion and Coagulation Management in Trauma Patients After the Introduction of a Coagulation Algorithm
NCT02569606
Major Liver Resection: Early Clotting Disorders and Functional Impairment.
NCT02813538
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Severe trauma patients
All severe trauma patients (ISS\>15) admitted in our trauma center Blood samples (additional blood tubing)
Blood samples
Investigators analyze hematological parameters with blood sampled daily in severe trauma patients
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Blood samples
Investigators analyze hematological parameters with blood sampled daily in severe trauma patients
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Polytrauma with ISS Score \> 15
* Hospitalized patients in reanimation unit \< 4h after trauma
* Informed consent
Exclusion Criteria
* Pregnant or lactating women
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Montpellier
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pauline PD DERAS, MD
Role: PRINCIPAL_INVESTIGATOR
Regional Trauma Center, Department of Anesthesiology and critical care, Lapeyronie University Hospital, Montpellier
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Anesthesiology and critical care, Lapeyronie University Hospital
Montpellier, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
9239
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.